Assessing immune inflammation in Behçet's disease
Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity
This study is testing how certain blood markers related to inflammation can help us understand Behçet's disease better and see how it affects patients compared to healthy people.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Trial ID | NCT06729112 on ClinicalTrials.gov |
What this trial studies
This study evaluates the pan-immune-inflammation value (PIN) in patients with Behçet's disease (BD) compared to healthy controls. It aims to correlate PIN with demographic and clinical characteristics of BD patients, as well as with disease activity. The study focuses on the role of various blood cell counts and ratios in understanding systemic inflammation and its impact on the disease. By analyzing these parameters, the research seeks to enhance the understanding of BD and its inflammatory processes.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with Behçet's disease according to established criteria.
Not a fit: Patients with other autoimmune diseases, malignancies, infections, or those who are pregnant or lactating may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new biomarker for assessing disease activity in Behçet's disease, leading to better management and treatment strategies.
How similar studies have performed: Previous studies have shown that similar immune-inflammatory biomarkers can effectively predict disease activity in rheumatologic disorders, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult BD patients who fulfilling the criteria for the diagnosis by International Team for the Revision of the International Criteria for Bechet's Disease . * Accept to participate in the current study. Exclusion Criteria: * Individuals with other autoimmune diseases. * Patients unwilling to participate in the study. * Patients less than 18 years old. * Patients with malignancy or infections. * Pregnancy and lactation
Where this trial is running
Asyut
- Assiut University Hospitals — Asyut, Egypt (Recruiting)
Study contacts
- Principal investigator: Sara Farrag, Lecturer — Assiut University
- Study coordinator: Sara Farrag, Lecturer
- Email: sara_farrag@aun.edu.eg
- Phone: +201097767735
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.